X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3010) 3010
Publication (152) 152
Book Chapter (70) 70
Book Review (48) 48
Conference Proceeding (4) 4
Web Resource (3) 3
Book / eBook (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
heparin-induced thrombocytopenia (2622) 2622
humans (1963) 1963
thrombocytopenia - chemically induced (1008) 1008
index medicus (988) 988
heparin - adverse effects (986) 986
hematology (937) 937
female (806) 806
male (784) 784
thrombosis (708) 708
anticoagulants - adverse effects (653) 653
peripheral vascular disease (589) 589
middle aged (584) 584
heparin (581) 581
aged (564) 564
thrombocytopenia (563) 563
anticoagulants - therapeutic use (473) 473
anticoagulants (412) 412
antibodies (410) 410
molecular-weight heparin (406) 406
adult (365) 365
diagnosis (350) 350
argatroban (347) 347
anticoagulation (346) 346
thrombocytopenia - diagnosis (305) 305
unfractionated heparin (303) 303
cardiopulmonary bypass (296) 296
surgery (279) 279
cardiac & cardiovascular systems (259) 259
thrombocytopenia - drug therapy (259) 259
risk factors (243) 243
platelet count (233) 233
management (232) 232
hit (224) 224
heparin‐induced thrombocytopenia (223) 223
anticoagulants - administration & dosage (220) 220
platelet factor 4 - immunology (218) 218
thrombocytopenia - immunology (216) 216
pharmacology & pharmacy (214) 214
heparin - immunology (211) 211
heparin - therapeutic use (204) 204
therapy (199) 199
animals (198) 198
treatment outcome (194) 194
aged, 80 and over (188) 188
fondaparinux (183) 183
recombinant hirudin (181) 181
venous thromboembolism (179) 179
platelets (177) 177
lepirudin (174) 174
thrombocytopenia - blood (168) 168
medicine & public health (166) 166
anesthesiology (165) 165
recombinant proteins - therapeutic use (161) 161
risk (158) 158
bivalirudin (155) 155
retrospective studies (154) 154
medicine, general & internal (151) 151
pipecolic acids - therapeutic use (151) 151
heparin induced thrombocytopenia (147) 147
platelet activation (144) 144
respiratory system (143) 143
deep-vein thrombosis (141) 141
glycosaminoglycans (134) 134
thrombocytopenia - complications (134) 134
abridged index medicus (131) 131
enzyme-linked immunosorbent assay (131) 131
critical care medicine (130) 130
thrombocytopenia - therapy (129) 129
thrombin (127) 127
thromboembolism (127) 127
prevention (122) 122
hirudin (115) 115
thrombosis - etiology (115) 115
hemodialysis (113) 113
care and treatment (111) 111
direct thrombin inhibitors (111) 111
thrombocytopenia - etiology (109) 109
platelet factor 4 (108) 108
partial thromboplastin time (105) 105
time factors (105) 105
thrombin - antagonists & inhibitors (104) 104
thrombosis - drug therapy (104) 104
warfarin (104) 104
analysis (101) 101
fibrinolytic agents - therapeutic use (101) 101
danaparoid (98) 98
prospective studies (98) 98
health aspects (97) 97
patient (97) 97
percutaneous coronary intervention (97) 97
thrombosis - prevention & control (95) 95
acute myocardial-infarction (94) 94
antibodies - blood (93) 93
blood coagulation - drug effects (93) 93
heparin - administration & dosage (93) 93
pregnancy (93) 93
disseminated intravascular coagulation (92) 92
dose-response relationship, drug (92) 92
pipecolic acids - administration & dosage (92) 92
blood clot (89) 89
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2662) 2662
German (156) 156
French (88) 88
Japanese (77) 77
Spanish (28) 28
Polish (12) 12
Chinese (10) 10
Czech (8) 8
Italian (7) 7
Russian (7) 7
Turkish (7) 7
Korean (6) 6
Lithuanian (2) 2
Dutch (1) 1
Hungarian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Primary Care - Clinics in Office Practice, ISSN 0095-4543, 12/2016, Volume 43, Issue 4, pp. 543 - 557
Journal Article
BLOOD, ISSN 0006-4971, 05/2017, Volume 129, Issue 21, pp. 2864 - 2872
Heparin-induced thrombocytopenia (HIT) is an immune complication of heparin therapy caused by antibodies to complexes of platelet factor 4 (PF4) and heparin.... 
FACTOR 4/HEPARIN ANTIBODIES | ORTHOPEDIC-SURGERY | MOLECULAR-WEIGHT HEPARIN | PLATELET-AGGREGATION TEST | FC-GAMMA-RIIA | HEMATOLOGY | CARDIOPULMONARY BYPASS-SURGERY | TISSUE FACTOR EXPRESSION | 4TS SCORING SYSTEM | UNFRACTIONATED HEPARIN | THROMBOEMBOLIC COMPLICATIONS
Journal Article
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 11/2017, Volume 15, Issue 11, pp. 2099 - 2114
Summary Autoimmune heparin‐induced thrombocytopenia (aHIT) indicates the presence in patients of anti‐platelet factor 4 (PF4)–polyanion antibodies that are... 
platelet factor 4 (PF4) | autoimmunity | platelet‐activating antibodies | heparin‐induced thrombocytopenia | high‐dose intravenous immunoglobulin | high-dose intravenous immunoglobulin | heparin-induced thrombocytopenia | platelet-activating antibodies | FACTOR 4/HEPARIN ANTIBODIES | FONDAPARINUX | WARFARIN THROMBOPROPHYLAXIS | IN-VITRO | CONFORMATIONAL-CHANGES | ORTHOPEDIC-SURGERY | CARDIAC-SURGERY | CROSS-REACTIVITY | PERIPHERAL VASCULAR DISEASE | PLATELET ACTIVATION | HEMATOLOGY | platelet factor4 (PF4) | CLINICAL-PRACTICE | Blood Platelets - immunology | Anticoagulants - administration & dosage | Administration, Oral | Autoantibodies - blood | Humans | Immunologic Factors - administration & dosage | Platelet Factor 4 - immunology | Immunoglobulins, Intravenous - administration & dosage | Anticoagulants - adverse effects | Heparin - adverse effects | Purpura, Thrombocytopenic, Idiopathic - blood | Purpura, Thrombocytopenic, Idiopathic - drug therapy | Heparin - immunology | Animals | Anticoagulants - immunology | Blood Coagulation - drug effects | Blood Platelets - metabolism | Partial Thromboplastin Time | Purpura, Thrombocytopenic, Idiopathic - immunology | Purpura, Thrombocytopenic, Idiopathic - chemically induced | Platelet Activation - drug effects | Blood Platelets - drug effects | Autoimmunity - drug effects | Thrombocytopenia | Autoimmunity | Fibrin | Medical examination | Immunoglobulin G | Anticoagulants (Medicine) | Sulfates | Blood | Anticoagulants | Immunoglobulins | Intravenous administration | Immune response | Disseminated intravascular coagulation | Polyphosphates | Catheters | Immunosuppressive agents | Recruitment | Thromboplastin | Platelet factor 4 | Polyanions | Side effects | Fibrinogen | Chondroitin sulfate | Heparin | Sulfate | Platelets | Antigen-antibody complexes
Journal Article
Chest, ISSN 0012-3692, 06/2008, Volume 133, Issue 6, pp. 340S - 380S
Journal Article
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, ISSN 1520-4391, 2012, Volume 2012, pp. 191 - 197
Journal Article